CITRYLL Trademark

Trademark Overview


On Tuesday, July 21, 2020, a trademark application was filed for CITRYLL with the United States Patent and Trademark Office. The USPTO has given the CITRYLL trademark a serial number of 79293817. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by Citryll BV. The CITRYLL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the prevention or treatment of autoimmune diseases; small molecules, gene therapies and peptides for the prevention or treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis
citryll

General Information


Serial Number79293817
Word MarkCITRYLL
Filing DateTuesday, July 21, 2020
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6481068
Registration DateTuesday, September 14, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the prevention or treatment of autoimmune diseases; small molecules, gene therapies and peptides for the prevention or treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCitryll BV
Party Type30 - Original Registrant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameCitryll BV
Party Type20 - Owner at Publication
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameCitryll BV
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Trademark Events


Event DateEvent Description
Monday, March 21, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 2, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 1, 2022FINAL DISPOSITION PROCESSED
Tuesday, December 14, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 14, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 20, 2020REFUSAL PROCESSED BY IB
Friday, November 27, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 27, 2020REFUSAL PROCESSED BY MPU
Thursday, November 26, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 25, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 24, 2020NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, November 7, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 6, 2020NON-FINAL ACTION WRITTEN
Thursday, November 5, 2020ASSIGNED TO EXAMINER
Tuesday, September 22, 2020APPLICATION FILING RECEIPT MAILED
Friday, September 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 17, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB